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The non-hydrolyzable GTP analogue, guanosine S-O-(3-thiotriphosphate) (GTPyS) and cyclic AMP poten- 
tiated the Caz +-evoked secretion of cr-melanocyte-stimulating hormone (a-MSH) from permeabilized neu- 
rointermediate lobe (IL) cells of rat pituitary gland. The enhancement by Mg-GTPyS (100 PM) and cyclic 
AMP (1 PM) depended on the intracellular Ca* + concentration (EC,, =4.8 f 1.8 and 4.6 + 1.7 ,uM; mean 
f SE, with and without Mg-GTPyS and cyclic AMP, respectively). A similar effect was observed with gua- 
nine nucleotide triphosphate (GTP and GppNHp). Mg was absolutely required for this event. Neither Mg- 
GTPyS nor cyclic AMP alone was effective in potentiating a-MSH secretion. GDP@ blocked the Mg- 
GTPyS (100 PM) and cyclic AMP augmented secretion of a-MSH. Neither neomycin (which affects the pro- 
cess of inositol 1,4,5-triphosphate-mediated Ca* + mobilization) or colchicine (which influences microtubule 
assembly) had an effect on the cyclic AMP and Mg-GTPyS potentiation of a-MSH secretion. These data 
suggest that the GTP-binding protein may be involved in the regulation of a-MSH secretion after Ca* + 
entry into the cells, since the intracellular environment is controlled in the permeabilized cells. 
GTP; Permeabilization; cyclic AMP; Exocytosis; (Pituitary intermediate cell) 
1. INTRODUCTION 
Many cellular responses to a hormonal stimulus 
appear to involve guanine nucleotide exchange 
reactions, including visual reception (transducin) 
[ 1,2], the hormone receptor-adenylate cyclase 
system for signal transduction (G,, Gi) [3-71, 
microtubular assembly (tubulin) [8] and the initia- 
tion of protein synthesis in eukaryotic cells (eIF-2) 
[9]. In general, there is agreement regarding the 
need and importance of GTP-binding proteins for 
many biochemical processes [ 10,111. 
Recently, Cockcroft and Gomperts [12] pro- 
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posed a novel GTP-binding protein (Gp) which 
might be involved in coupling to polyphosphoino- 
sitide (PPI) phosphodiesterase. In the previous 
paper we described for the first time that cyclic 
AMP and Mg-GTPyS potentiates Ca2+-evoked cy- 
melanocyte-stimulating hormone (wMSH) secre- 
tion from permeabilized rat pituitary intermediate 
lobe (IL) cells [13]. The intracellular environment 
was controlled experimentally by Ca’+-EGTA buf- 
fers after permeabilization of melanotrophs by 
brief exposure to intense electrical fields. 
Here, we investigated further the effect of GTP 
analogues and evaluated the possible involvement 
of a GTP-binding protein in the secretion of (Y- 
MSH from rat melanotrophs. Our data suggest 
that a novel GTP-binding protein might par- 
ticipate in exocytotic events from permeabilized IL 
cells. 
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2. MATERIALS AND METHODS 
2.1. Materials 
Culture medium was obtained from Gibco 
(Grand Island, NY), ATP, cyclic AMP, CTP, 
ITP, GTP, GMP, cyclic GMP, colchicine and 
neomycin from Sigma (St. Louis, MO), and 
guanosine 5 ’ -0-(3-thiotriphosphate) (GTPyS) and 
guanosine 5 ’ -0-(2-thiodiphosphate) (GDP@) 
from Boehringer Mannheim. All reagents were of 
analytical grade. 
2.2. Methods 
A previously described procedure was used to 
disperse enzymatically IL cells from the 
neurointermediate lobe of 250-300 g Sprague- 
Dawley rats [ 141 and to quantify the secretion of cy- 
MSH from these cells [15] with several modifica- 
tions [16]. 
The solution used for cell permeabilization con- 
tained: 146 mM sodium acetate, 5 mM KCl, 1 mM 
NazHPOd, 5 mM Hepes (pH 7.4), 1.5 mM CaCl2 
and 7.8 mM glucose. Solutions free of ionized 
calcium were prepared by omitting the CaC12 and 
adding 1 mM EGTA. 
For some experiments, Ca2+-EGTA-buffered 
solutions were prepared by varying the concentra- 
tion of calcium and then adjusting the pH to 7.4 by 
addition of NaOH [ 171. The concentration of Ca2+ 
was determined with a calcium-sensitive electrode 
(Orion Research) [18]. All solutions were gassed 
with a mixture of 95% 02 and 5% CO2 before use. 
Cells were permeabilized using the method of 
Knight and Baker [19] with several modifications 
[13]. In brief, the dispersed cells were mixed with 
3 vols (5.0 x lo6 cells/ml) of Ca’+-free 
permeabilizing solution and washed once by cen- 
trifugation. The cells were resuspended in 1 ml of 
the same solution (8-10 x lo6 cells/ml) and 
permeabilized by double exposure to an intense 
electric field (each exposure to a field strength of 
2.0 kV/cm; time constant 200 ps). The suspension 
of cell was diluted lo-fold with Ca2+-free 
permeabilizing solution, centrifuged and 
resuspended in the same solution at 2 x lo6 
cells/ml. Induction of secretion was started im- 
mediately following permeabilization by transfer- 
ring 0.05 ml of the cell suspension to 0.95 ml 
permeabilizing solution containing test substances. 
Routinely, the cells were incubated for 5 min at 
30°C. Incubation was terminated by centrifuga- 
tion in a Beckman microfuge, and removal of an 
aliquot of the supernatant solution for assay of IR 
wMSH. Zero-time samples were taken by cen- 
trifuging the complete assay system without the 
5 min incubation. All assays were performed in 
triplicate. Statistical significance was determined 
with Student’s t-test. 
3. RESULTS 
In permeabilized IL cells, wMSH secretion was 
stimulated by free Ca2+ in a concentration- 
dependent manner (fig. 1). Half-maximal stimula- 
tion of cu-MSH by Ca2+ was reached at 4.8 f 
1.8 M (mean f SE, n = 4) with the use of 
Ca2+-EGTA-buffered medium. Cyclic AMP 
(1 PM) and GTPyS (100 PM) augmented the 
amount of cu-MSH secreted in response to Ca2+ 
without altering the molar potency of the ion (EC50 
= 4.6 + 1.7 FM). Fig. 1 summarizes the results of 
a series of experiments in which the concentration 
of Ca2+ was varied with Ca’+-EGTA buffers (as 
described in section 2). Although the half-maximal 
effect of Ca2+ in the presence and absence of 
GTPyS and cyclic AMP was not significantly 
changed, more pronounced secretion of wMSH 
0L4M 10-g 10-7 
CALCIUM (M) 
Fig.1. Ca*+ dependence of LY-MSH secretion from 
permeabilized IL cells. The concentrations of free Ca2+ 
in the Ca’+-EGTA buffers were measured as described 
in section 2. (0) None, (0) 1 pM cyclic AMP and 
100 pM GTP+. 
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was seen in the presence of Mg-GTPyS and cyclic 
AMP. The magnitude of cyclic AMP- and Mg- 
GTPyS-enhanced a-MSH secretion was 2-fold 
greater than that of Ca2+-evoked secretion within 
5 min of incubation. Mg was also absolutely re- 
quired for this event. 
In the absence of Ca*+, Mg-GTPyS and cyclic 
AMP were virtually ineffective in stimulating LY- 
MSH secretion. Mg-GTPyS-augmented hormonal 
secretion was concentration-dependent; half- 
maximal potentiation of secretion occurred at ap- 
prox. 5 PM Mg-GTPyS (fig.2). As may be seen 
from this figure, GTP as well as its non- 
hydrolyzable analogues, GTPyS and GppNHp, in 
the presence of cyclic AMP (1 ,uM) caused 
concentration-dependent potentiation of wMSH 
secretion from permeabilized cells. Other guanine 
nucleotides, GDP@, GMP and cyclic GMP (each 
at lOOrM), however, were without effect. GDP 
was the only substance that affected the secretion 
of wMSH (25% of maximal GTPyS effect). None 
of the other nucleotides tested (ATP, CTP and 
ITP), at concentrations up to 100 PM, had any ef- 
fect on cyclic AMP potentiation of CX-MSH secre- 
tion (table 1). 
6- 
1 1 
OL O+V 
NUCLEOTIDE lpMl 
Fig.%. Effects of GTP analogues on wMSH secretion. 
Permeabilized cells were incubated for 5 min at 3O”C, in 
the presence of 1 PM cyclic AMP and various 
concentrations of GTPyS (0) and GppNHp (0). Each 
value is the mean k SE for three determinations. 
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Table 1 
Effect of nucleotides on the secretion of (Y-MSH 
potentiated by cyclic AMP (1 PM) in the presence of 
1.5 mM CaClz 
% of maximum potentiation 
by GTPrS and cyclic AMP 
GTPyS 100 
GTP 97 f 7 
GPPNHP 83 + 7 
GDP 39 k 4 
GMP 17 k 5 
Cyclic GMP 18 it_ 4 
ATP 33 -e 5 
CTP 11 + 2 
ITP 18 + 4 
The concentration of each nucleotide was 100,~M, the 
control value 2.86 + 0.18 ng (u-MSH/~O’ cells and the 
value of potentiation by cyclic AMP (1 PM) and GTPrS 
(100 PM) 5.97 f 0.35 ng a-MSH/105 cells. Each value is 
the mean k SE for three determinations 
The augmented secretion of cu-MSH by Mg- 
GTPyS and cyclic AMP was significantly inhibited 
by the concomitant presence of GDPpS (fig.3). 
r 1 
t 
n 
CAMP - + - •t + 
GTPyS - - + f + 
MgZ’ + - + 
GDP/3S - - - - - 
I     
Fig.3. Effect of Mg on the potentiated secretion of LY- 
MSH by cyclic AMP (1 pM) and GTPyS (100 PM) in the 
presence of 1.5 mM CaClz. Each value is the mean k SE 
for three determinations. * Significantly different from 
control. p < 0.05 by Student’s t-test. 
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Control Neomycin Colchicine 
Fig.4. Effect of neomycin and colchicine on the 
potentiation of cu-MSH secretion by cyclic AMP and 
GTPyS (100 PM) in the presence of 1.5 mM CaC12. 
Each value is the mean -t SE for three determinations. 
Mg-GDP,&, at lOOpM, virtually abolished the 
Mg-GTPyS-induced stimulation of wMSH 
secretion. 
Neomycin (100 PM), an inhibitor of phos- 
pholipase C-catalyzed hydrolysis of phosphatidyl- 
inositol 4,5bisphosphate, did not block 
GTPyS-mediated potentiation of cu-MSH secretion 
by cyclic AMP (fig.4). Colchicine (1 mM) had no 
effect on the secretion of wMSH from 
permeabilized cells. 
4. DISCUSSION 
As reported before, the technique of Baker and 
Knight [19] was applied in order to investigate the 
mechanisms of exocytosis in the intermediate lobe 
of the pituitary gland [13]. The results obtained 
from these studies showed that permeabilized IL 
cells retain functional secretory potency and that 
Ca2+-evoked wMSH secretion can be potentiated 
by cyclic AMP in the presence of Mg-GTPyS. 
Both guanine nucleotide triphosphate and Mg2+ 
are absolutely required for potentiation of 
Ca2+-evoked wMSH secretion by cyclic AMP. 
The results clearly indicate that only GTP and its 
analogues (GTPyS and GppNHp) potentiate cy- 
MSH secretion, other nucleotides being ineffec- 
tive. Mg-ATP by itself potentiates Ca’+-evoked (Y- 
MSH secretion at higher concentration (over 
300 PM, maximum at 1 mM) as reported in [ 131. 
It is of great interest that the cyclic AMP effect 
on hormonal secretion is most pronounced in the 
presence of a non-hydrolyzable guanine 
nucleotide. Generally, it is known that GTP- 
binding proteins regulate activities of hormone- 
sensitive adenylate cyclase [3-7,201, voltage- 
dependent ion channels [21-231 and polyphos- 
phoinositide (PPI) phosphodiesterase [ 12,24,25]. 
Guanine nucleotides have already been shown to 
be involved in the biochemical physiology of the 
melanotroph: these nucleotides are essential for 
the P-adrenergic enhancement and D-2 dopaminer- 
gic inhibition of adenylate cyclase activity [26-281. 
The guanine nucleotide regulatory proteins N, and 
Ni presumably mediate the stimulation and inhibi- 
tion of melanotroph adenylate cyclase activity, 
respectively. Thus, it is feasible that GTP ana- 
logues act on N, and not on Ni leading to elevation 
of the level of cyclic AMP, since exogenous cyclic 
AMP is required for stimulation. However, cyclic 
AMP added exogenously, by itself, does not 
potentiate Ca2+ -evoked a-MSH secretion at con- 
centrations up to 1OOpM (not shown). Further- 
more, Mg-GTP analogues alone are also inactive 
and the slight stimulation of adenylate cyclase ac- 
tivity by GTP analogues appears after 6 min of in- 
cubation in homogenates of IL tissues as reported 
by Cote et al. [26]. Our results showing potentia- 
tion of secretion by cyclic AMP and Mg-GTP 
analogues within 5 min (not shown), are not con- 
sistent with possible stimulation of N, by GTP 
analogues [26,29,30]. Therefore, it is unlikely that 
GTP analogues interact with the GTP-binding pro- 
tein coupled to adenylate cyclase. 
It is also unlikely that the potentiation of secre- 
tion by cyclic AMP and Mg-GTP analogues results 
from a change of some ion channels (i.e. Ca2+ 
channel, K+ channel, etc.) [22,23], since low-M, 
substances are controlled in the permeabilized cells 
and neomycin is ineffective. 
Moreover, we can exclude the possibility of GTP 
analogues interacting with GTP-binding protein 
coupled to PPI-phosphodiesterase (Np) [12], since 
neomycin did not inhibit the potentiated secretion 
of cu-MSH by cyclic AMP and Mg-GTP analogues. 
It is also known that tubulin requires GTP for 
polymerization and that GTP is hydrolyzed during 
microtubular assembly [8,9,24]. Therefore, we ex- 
amined the possibility of cyclic AMP- and Mg- 
GTP analogue-augmented a-MSH secretion in 
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relation to microtubules with the use of colchicine. 
However, this agent did not affect cu-MSH secre- 
tion either with or without the presence of cyclic 
AMP and Mg-GTP analogues. Moreover, both 
membrane fusion [31] and microtubule assembly 
are also sensitive to guanine nucleotides at relative- 
ly higher concentrations (5-10 mM), but these 
sites are unlikely to be included in cyclic AMP 
potentiation of a-MSH secretion, since the 
specificity and efficacy for nucleotides are quite 
different in the microtubular system [8]. 
Finally, the involvement of nucleotide 
regulatory protein (defined N,), coupled to other 
unknown systems as a family with N, and Ni 
[32-341, should be considered as part of the pro- 
cesses of hormonal secretion, however it is not 
likely because both basal and @agonist-stimulated 
hormone secretion from intact dispersed IL cells 
remain unchanged after pretreatment with or 
without pertussis toxin as reported by Cote et al. 
[35]. Even though this possibility cannot be exclud- 
ed completely, the present results strongly suggest 
that the cyclic AMP potentiation of Ca’+-evoked 
LU-MSH secretion may be regulated by GTP 
binding to a novel GTP-binding protein. Thus, 
these findings suggest that a unique GTP-binding 
protein may participate in the hormonal secretory 
process associated with modification of cyclic 
AMP-dependent events in the membrane. 
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